From: Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study
Variables | Pre-menopausal (n = 303) | Menopausal (n = 233) | Post-menopausal (n = 987) | P value* |
---|---|---|---|---|
Age (years) | 47.2 ± 2.1 | 51.5 ± 5.8 | 61.6 ± 8.5 | < 0.001 |
Systolic blood pressure (mmHg) | 120.2 ± 20.2 | 125.2 ± 23 | 132.4 ± 22.1 | 0.030 |
Diastolic blood pressure (mmHg) | 77.8 ± 11.8 | 80.3 ± 12.8 | 82.5 ± 11.8 | 0.008 |
Fasting plasma glucose (mg/dl) | 88.7 ± 29.7 | 91.2 ± 34 | 95.1 ± 38.2 | 0.393§ |
2 h-post-prandial glucose (mg/dl) | 115 ± 53.4 | 121 ± 67.4 | 127.3 ± 70.2 | 0.011§ |
Total Cholesterol (mg/dl) | 209.8 ± 44.6 | 233.6 ± 54.6 | 233.3 ± 50.6 | < 0.001†|
LDL-C (mg/dl) | 127.2 ± 38.2 | 142.8 ± 47.3 | 142.5 ± 43.5 | 0.004†|
Triglycerides (mg/dl) | 176.1 ± 98.9 | 213.7 ± 118.1 | 207.8 ± 104.9 | < 0.001†|
HDL-C (mg/dl) | 48.3 ± 10.1 | 50.4 ± 11 | 49.5 ± 10.8 | 0.121 |
Waist (cm) | 97.6 ± 12.5 | 97.2 ± 13.4 | 98.5 ± 12.3 | 0.197 |
Waist to hip ratio | 0.92 ± 0.07 | 0.93 ± 0.08 | 0.95 ± 0.07 | 0.391 |
Body mass index | 28.6 ± 4.7 | 28.3 ± 5.1 | 27.6 ± 4.5 | 0.932 |
Anti diabetes medication | 12(4%) | 13(5.6%) | 115(11.7%) | 0.003 |
Anti hypertension medication | 35(11.6%) | 48(20.6%) | 324(32.9%) | 0.153 |
Global Dietary Index | 0.90 ± 0.23 | 0.87 ± 0.23 | 0.84 ± 0.27 | 0.630 |
Leisure Time Physical Activity | 62.40 ± 82.37 | 66.19 ± 88.04 | 62.09 ± 82.54 | 0.482 |